Introducing our new Biosensor that detects & identifies numerous virus & bacteria targets in a single test in under 60 seconds including COVID, Flu, RSV & Strep
We're thrilled that the study of our new Multiplex Biosensor has been published in the journal Sensors that can detect & identify multiple virus & bacteria pathogens in a single test, including COVID, Flu, RSV, & Step, in an astonishing 60 seconds!
https://t.co/Sq1YEMO5qy
COVID Detection in 60 Seconds: Opteev’s #Biosensor Breakthrough Published in “Sensors” Journal Signals Revolution in #PandemicPreparedness https://t.co/HX6KaYoj5V @opteev
Watch our latest video that showcases the unprecedented potential of our Multiplex Biosensor that can detect and identify a high array of virus and bacteria pathogen targets in a single test in under 60 seconds!
https://t.co/62csJkDqA5
@RachelTobac We've developed the biosensor but need additional funding (not much) to commercialize it into a diagnostic device. So we're seeking partnerships w/ MedTech or Healthcare orgs to get this incredible tech to the masses ASAP. Pls spread the word!!! [email protected]
We're thrilled that the study of our new Multiplex Biosensor has been published in the journal Sensors that can detect & identify multiple virus & bacteria pathogens in a single test, including COVID, Flu, RSV, & Step, in an astonishing 60 seconds!
https://t.co/Sq1YEMO5qy
Opteev is seeking partnerships with healthcare organizations & diagnostic manufacturers to unlock the massive potential of our new biosensor so that we can equip healthcare providers with this technology ASAP. For collaborations & potential partnerships, email [email protected]
It is estimated that a comprehensive diagnostic that can be used at the point of care can lead to a 54% reduction in fatalities. That's over 540,000 lives that our technology has the power to save EACH YEAR in the U.S. alone!
Currently over 70% of respiratory infections are diagnosed based on symptoms not with precise diagnostics. This educated guesswork can lead to dire consequences.
Our new Multiplex Biosensor paves the way for the first comprehensive multiplex syndromic diagnostic that can be used at the Point of Care with instantaneous results https://t.co/9TSmiiAGN9
Hi @c_demur, we'd love to collaborate! Please check out our press release:
https://t.co/6XFP5qTK2X
Opteev Develops World's First Multiplex Biochip That Precisely Identifies COVID, Flu, RSV, and Respiratory Pathogens in Under 1 Minute
@opteev has filed a patent for a multiplex #biochip that offers the potential to test multiple pathogens responsible for respiratory infections, including SARS-CoV-2, RSV, & Influenza, & precisely identify the specific virus or bacteria in under 1 minute. https://t.co/4hTC4V1EMz
Visit with friends indoors and enjoy the company without the risk of COVID infection.
ViraWarn Plus is your personal space COVID detector.
https://t.co/eP0cZCsKmj
RSV affects about 64 million people every year and results in an average 160,000 deaths.
RSV will persist, but you can get peace of mind with instant virus detection courtesy of ViraWarn Plus.
https://t.co/eP0cZCsKmj
ViraWarn is so easy to use, so convenient, and so affordable that it promotes testing even when you're not sick. Because that is the time you are most infectious to others!
Learn more!
https://t.co/eP0cZCsKmj
“While it’s clear that people w/ certain risk factors (including high blood pressure, smoking, diabetes, obesity & other conditions) more likely to have a serious bout of COVID-19, there isn’t a clear link between these risk factors & long-term problems.”
https://t.co/BdA9YDgRBl
Currently, most people only test for COVID when they wake up with a sore throat or achy joints, but how long have they been spreading the virus before becoming symptomatic?
Learn more
https://t.co/eP0cZCsKmj